Clinical trials
Coagulopathy clinical trials
Below are recruiting coagulopathy clinical trials, each written for real people, not researchers. We’re tracking 18 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06854640RecruitingPhase 1
Safety and dosing study for a new sepsis-related blood clotting treatment
This study tests a new drug (BAY 3389934) for people with sepsis who also have a blood clotting problem. It aims to find the right dose and make sure the drug is safe.
EdegemAges 18–80 - NCT07097337Recruiting
Quick fibrinogen test for trauma patients with heavy bleeding
This trial checks if a fast bedside test for fibrinogen (a protein that helps blood clot) can help guide treatment for trauma patients who are actively bleeding. It may lead to better care in the emergency department.
Rotterdam, South HollandAges 16 years+ - NCT06355258RecruitingPhase 1
Troxerutin to prevent blood clots in COVID-19 patients
This trial tests if the drug troxerutin can prevent dangerous blood clots in adults hospitalized with mild or severe COVID-19. If you have COVID-19 and are not already on blood thinners or at high risk for bleeding, you may be able to join.
Shaoxing, ZhejiangAges 18 years+ - NCT06037187Recruiting
Blood clotting study for immune skin diseases
This study looks at how immune-related skin diseases like bullous pemphigoid and lupus affect blood clotting. The results could help doctors better understand and manage clotting risks in these patients.
Omaha, NebraskaAges 19 years+ - NCT06736860RecruitingPhase 4
Tranexamic acid for trauma bleeding with blood clot monitoring
This study tests whether a drug called tranexamic acid (TXA) can help control bleeding in trauma patients. It uses a special blood test (thromboelastography) to monitor how well your blood clots during treatment.
Guangzhou, GuangdongAges 18–80 - NCT05874843Recruiting
Testing a bedside blood clot test in children
This trial checks whether a bedside machine (TEG 6s) can measure blood clotting in children during planned surgery. It may help doctors get faster, more accurate information about clotting during the operation.
Indianapolis, IndianaAges 3 months–18 years - NCT05334615Recruiting
Study of blood clot problems after COVID or flu
This study looks at blood clot–related complications after COVID-19 (and in some cases flu) in adults admitted to the hospital. It may help doctors better understand and manage these complications.
Iowa City, IowaAges 18–99 - NCT05449834RecruitingPhase 3
Testing early fibrinogen treatment after serious trauma bleeding
This Phase 3 study tests whether giving fibrinogen early can improve outcomes for adults with serious trauma who are actively bleeding. The goal is to help blood clotting work better sooner and potentially reduce complications from uncontrolled bleeding.
Newcastle, New South WalesAges 18–100 - NCT05629130Recruiting
Blocking blood vessel procedures for bleeding-related joint inflammation
This study looks at whether a “blocking” procedure (embolization) can improve long-lasting joint inflammation caused by inherited bleeding disorders. It focuses on people with joint lining inflammation from repeated bleeding into the joint.
São PauloAges Any age - NCT06100718Recruiting
Detecting new cancer after a stroke in at-risk patients
This study looks for hidden cancers in people who have had a stroke and have high levels of a blood marker called D-dimer. It aims to see if a full cancer screening one year later can find new cancers that might have been missed.
Lausanne, Canton of VaudAges 18 years+ - NCT06304714Recruiting
Effects of Bothrops snake venom on bleeding risk
This study looks at how Bothrops snake venom affects a blood protein called von Willebrand factor, which helps with clotting. If you have been bitten by a Bothrops snake and have moderate to severe symptoms, you may be able to join to help doctors understand how to treat snakebites better.
Fort-de-France, MartiniqueAges 18 years+ - NCT06705829Recruiting
Comparing blood clotting tests for clotting factor deficiencies
This trial compares different blood test reagents to see which works best for measuring clotting time in people with clotting factor deficiencies or liver disease. It may help doctors choose the right test for your condition.
StrasbourgAges 18 years+ - NCT06831565Recruiting
Comparing two blood-transfusion strategies for liver patients before procedures
This trial tests whether using a slightly different target on a blood-clotting test (ROTEM) can reduce the need for blood transfusions in people with liver disease who need a procedure. If you have cirrhosis or ACLF with severe clotting problems, this study may help your doctors decide how much blood product to give you before the procedure.
New Delhi, National Capital Territory of DelhiAges 18–75 - NCT06878105Recruiting
Blood management study for surgical patients
This study looks at how hospitals manage your blood during and after planned surgeries that have a moderate to high risk of bleeding. It aims to find better ways to reduce blood loss and the need for transfusions.
BudapestAges 18 years+ - NCT06891131Recruiting
Blood transfusion bundle for severe bleeding after injury
This trial tests a standard set of emergency blood transfusions for people with life-threatening bleeding from a serious injury. It aims to improve survival by giving blood products quickly before reaching the hospital.
GrazAges 18 years+ - NCT06891599Recruiting
Blood test for clotting in sepsis and trauma ICU patients
This study is testing a special blood test called ROTEM to see how well it can predict bleeding problems in ICU patients with sepsis or severe trauma. It may help doctors give the right treatment faster.
StockholmAges 18 years+ - NCT07046858Recruiting
Blood markers to predict trauma complications
This study looks at two simple blood test markers (PLR and PNR) to see how well they predict hidden injuries in trauma patients. If you've had a recent injury and your blood is tested in the ER, you may be able to join.
Thrissur, KeralaAges 12 years+ - NCT07230067Recruiting
Sepsis with low platelets: platelet transfusion study
This study looks at whether platelet transfusions help patients with sepsis and very low platelet counts recover better. If you or your loved one had sepsis, a low platelet count, and were in the ICU for at least two days, this trial may be relevant.
Guangzhou, GuangdongAges 18 years+
Hear when a new Coagulopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for coagulopathy?
- Yes. Clin2 currently lists 18 recruiting coagulopathy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a coagulopathy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a coagulopathy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.